Andere talen VGI Health Technology Limited

Aandelen

VTL

AU0000152597

slotkoers National Stock Exchange of Australia Andere beurzen 00:00:00 29-06-2023			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,02 ^AUD	-33,33%		-.--%	-.--%

08/02	VGI Health Technology Limited rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI
2023	VGI Health Technology Limited rapporteert winstresultaten voor het volledige jaar eindigend op 30 juni 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

VGI Health Technology Limited New Partnership	14/02
VGI Health Technology Limited (NSX:VTL) New Partnership	14/02
VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023	08/02
VGI Health Technology Limited HREC Approval for Phase II Clinical Study	10/01
VGI Health Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023	07-09-23
VGI Health Technology Limited commences divestment of Invictus BioPharma Pty Ltd	29-08-23
VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd	29-08-23
Certain Ordinary Shares of VGI Health Technology Limited are subject to a Lock-Up Agreement Ending on 28-MAY-2023.	28-05-23
VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2022	16-02-23
VGI Health Technology Limited Quarterly Update	30-01-23
VGI Health Technology Limited (NSX:VTL) Quarterly Update	30-01-23
VGI Health Technology Limited Update on Sale of Invictus BioPharma	21-12-22
VGI Health Technology Limited (NSX:VTL) Update on Sale of Invictus BioPharma	21-12-22
VGI Health Technology Limited R & D Facility Agreement with Fundsquire Pty Ltd	13-10-22
VGI Health Technology Limited (NSX:VTL) R & D Facility Agreement with Fundsquire Pty Ltd	13-10-22
VGI Health Technology Limited NAFLD/NASH Phase II Clinical Study	04-10-22
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH Phase II Clinical Study	04-10-22
VGI Health Technology Limited Receives Ethics Approval for US Clinical Study	25-09-22
VGI Health Technology Limited NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient	13-09-22
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient	13-09-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen VGI Health Technology Limited

Aandelen

VTL

AU0000152597

Andere talen

Filters